SCHEMBL9166162

SCHEMBL9166162

O=C(OCc1ccccc1)c1cc(O)cc(O)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.72
KMT2A Q03164 3/20 0.72
SLC6A2 P23975 1/20 0.72
SLC6A3 Q01959 1/20 0.72
LMNA P02545 3/20 0.71
RAB9A P51151 3/20 0.62
NPC1 O15118 2/20 0.62
ALDH1A1 P00352 6/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.56
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA9 Q16790 1/20 0.56
CA14 Q9ULX7 1/20 0.56
MEN1 O00255 1/20 0.56
L3MBTL1 Q9Y468 2/20 0.53
MAPK1 P28482 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9696689 0.96 TDP1 (0.72) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL18736538 0.93 TDP1 (0.64) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL21924208 0.91 KMT2A (0.66) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL8862300 0.90 KMT2A (0.68) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL6282770 0.90 KMT2A (0.81) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL18736257 0.90 TDP1 (0.64) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL6655185 0.89 TDP1 (0.62) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL22498785 0.89 RAB9A (0.67) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL14166129 0.89 KMT2A (0.62) TDP1KMT2ASLC6A2SLC6A3LMNA
SCHEMBL20679851 0.86 NPC1 (0.56) TDP1KMT2ASLC6A2SLC6A3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-60219085-A None JP disclosed
CN-119233964-A Single component delivery system for nucleic acids 宾夕法尼亚大学理事会 2024-12-31 CN disclosed
CN-109305949-B Monomer, polymer, compensation film, optical film and display device 三星电子株式会社 2023-08-15 CN disclosed
US-11702509-B2 Monomer, polymer, compensation film, optical film, and display device SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-11702509-B2 Monomer, polymer, compensation film, optical film, and display device SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
US-11702509-B2 Monomer, polymer, compensation film, optical film, and display device SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-18 US disclosed
EP-3487923-B1 HIGH STRENGTH RUBBER COMPOSITION MICHELIN & CIE (FR) 2023-06-28 EP disclosed
US-11643579-B2 Adhesive composition comprising a phosphate salt and a thermosetting resin COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2023-05-09 US disclosed
WO-2022251191-A1 ONE-COMPONENT DELIVERY SYSTEM FOR NUCLEIC ACIDS THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2022-12-01 WO disclosed
US-20220127605-A1 NUCLEIC ACID CONJUGATE KYOWA KIRIN CO., LTD. (JP) 2022-04-28 US disclosed
WO-2017198967-A1 COMPOSITE AND POWER TRANSMISSION BELT COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2017-11-23 WO disclosed
WO-2017198968-A1 COMPOSITE AND POWER TRANSMISSION BELT COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2017-11-23 WO disclosed
EP-3102406-B1 RUBBER COMPOSITE REINFORCED BY AT LEAST ONE STEEL REINFORCING ELEMENT RENDERED ADHESIVE BY AN ADHESIVE COMPOSITION CONTAINING AROMATIC ALDEHYDE AND POLYPHENOL MICHELIN & CIE (FR) 2017-10-25 EP disclosed
US-5446189-A Diester intermediates for diacid enzyme inhibitor HOFFMANN-LA ROCHE INC. (US) 1995-08-29 US disclosed
US-5374772-A Skin disorders, antiinflammatory agents, cardiovascular disorders HOFFMANN-LAROCHE INC. (US) 1994-12-20 US disclosed
US-5324747-A Treatment of inflammatory diseases HOFFMANN-LA ROCHE INC. (US) 1994-06-28 US disclosed
EP-0601385-A1 Disubstituted benzoic acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1994-06-15 EP disclosed
US-5298652-A N-substituted glycines, inhibitors of phospholipase A2 HOFFMANN-LA ROCHE INC. (US) 1994-03-29 US disclosed
EP-0579066-A2 N-substituted anilines F. HOFFMANN-LA ROCHE AG (CH) 1994-01-19 EP disclosed
JP-S60219085-A RECORDING MATERIAL FUJI PHOTO FILM CO LTD 1985-11-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127605-A1 NUCLEIC ACID CONJUGATE NSUN3, NSUN2, RNASEH1 TDP1 613/4885KMT2A 1750/4885SLC6A2 1074/4885
US-11702509-B2 Monomer, polymer, compensation film, optical film, and display device PYM1, PADI1, COL1A1 TDP1 195/4885KMT2A 1684/4885SLC6A2 3504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.